Actinver Wealth Management Inc. Invests $1.13 Million in iShares Nasdaq Biotechnology ETF (IBB)

Actinver Wealth Management Inc. bought a new position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 11,760 shares of the financial services provider’s stock, valued at approximately $1,134,000.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Parkside Financial Bank & Trust bought a new stake in iShares Nasdaq Biotechnology ETF in the fourth quarter valued at $29,000. Sontag Advisory LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the fourth quarter worth about $32,000. Aspire Private Capital LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the fourth quarter worth about $40,000. Genesee Capital Advisors LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the fourth quarter worth about $42,000. Finally, Intercontinental Wealth Advisors LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the fourth quarter worth about $56,000. 65.59% of the stock is currently owned by institutional investors.

IBB stock traded down $1.16 during trading on Wednesday, reaching $105.64. The stock had a trading volume of 3,574,958 shares, compared to its average volume of 2,472,451. iShares Nasdaq Biotechnology ETF has a one year low of $89.01 and a one year high of $122.97.

ILLEGAL ACTIVITY NOTICE: “Actinver Wealth Management Inc. Invests $1.13 Million in iShares Nasdaq Biotechnology ETF (IBB)” was posted by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at https://www.baseballdailydigest.com/news/2019/04/24/11760-shares-in-ishares-nasdaq-biotechnology-etf-ibb-acquired-by-actinver-wealth-management-inc.html.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Read More: QQQ ETF

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.